WallStreetZenWallStreetZen

NASDAQ: BRKR
Bruker Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BRKR

Based on 7 analysts offering 12 month price targets for Bruker Corp

Min Forecast
$38.00+18.34%
Avg Forecast
$44.43+38.36%
Max Forecast
$50.00+55.71%

Should I buy or sell BRKR stock?

Based on 7 analysts offering ratings for Bruker Corp.

Buy
Strong Buy
3 analysts 42.86%
Buy
0 analysts 0%
Hold
4 analysts 57.14%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BRKR's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BRKR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BRKR stock forecasts and price targets.

BRKR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-05
lockedlocked$00.00+00.00%2025-08-05
lockedlocked$00.00+00.00%2025-08-04
lockedlocked$00.00+00.00%2025-08-04
lockedlocked$00.00+00.00%2025-06-26
UBS
Top 13%
88
HoldMaintains$45.00+40.14%2025-05-08
Goldman Sachs
Top 11%
90
HoldMaintains$45.00+40.14%2025-05-08

1 of 1

Forecast return on equity

Is BRKR forecast to generate an efficient return?

Company
22.04%
Industry
22.52%
Market
-21.43%
BRKR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BRKR forecast to generate an efficient return on assets?

Company
6.33%
Industry
11.89%
BRKR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BRKR earnings per share forecast

What is BRKR's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$2.00+284.29%
Avg 2 year Forecast
$2.32+345.83%
Avg 3 year Forecast
$2.64+408.33%
BRKR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

BRKR revenue forecast

What is BRKR's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$3.5B+0.48%
Avg 2 year Forecast
$3.6B+3.17%
Avg 3 year Forecast
$3.7B+8.14%
BRKR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BRKR earnings growth forecast

How is BRKR forecast to perform vs Medical Devices companies and vs the US market?

Company
111.21%
Industry
16.76%
Market
19.28%
BRKR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BRKR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BRKR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BRKR revenue growth forecast

How is BRKR forecast to perform vs Medical Devices companies and vs the US market?

Company
1.9%
Industry
7.16%
Market
11.8%
BRKR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BRKR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BRKR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BRKR$32.11$44.43+38.36%Buy
GKOS$82.10$123.60+50.55%Buy
IRTC$172.20$176.63+2.57%Strong Buy
TMDX$119.81$138.33+15.46%Buy
ITGR$102.69$139.50+35.85%Strong Buy
View Top Medical Device Stocks

Bruker Stock Forecast FAQ

Is Bruker Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: BRKR) stock is to Buy BRKR stock.

Out of 7 analysts, 3 (42.86%) are recommending BRKR as a Strong Buy, 0 (0%) are recommending BRKR as a Buy, 4 (57.14%) are recommending BRKR as a Hold, 0 (0%) are recommending BRKR as a Sell, and 0 (0%) are recommending BRKR as a Strong Sell.

If you're new to stock investing, here's how to buy Bruker stock.

What is BRKR's earnings growth forecast for 2025-2027?

(NASDAQ: BRKR) Bruker's forecast annual earnings growth rate of 111.21% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 16.76%, and it is also forecast to beat the US market's average forecast earnings growth rate of 19.28%.

Bruker's earnings in 2025 is $79,600,000.On average, 6 Wall Street analysts forecast BRKR's earnings for 2025 to be $303,180,807, with the lowest BRKR earnings forecast at $295,852,762, and the highest BRKR earnings forecast at $311,024,698. On average, 6 Wall Street analysts forecast BRKR's earnings for 2026 to be $351,731,004, with the lowest BRKR earnings forecast at $323,162,247, and the highest BRKR earnings forecast at $391,435,962.

In 2027, BRKR is forecast to generate $401,039,798 in earnings, with the lowest earnings forecast at $379,298,413 and the highest earnings forecast at $441,503,352.

What is BRKR's revenue growth forecast for 2025-2027?

(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 1.9% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.8%.

Bruker's revenue in 2025 is $3,442,800,000.On average, 4 Wall Street analysts forecast BRKR's revenue for 2025 to be $524,843,557,941, with the lowest BRKR revenue forecast at $523,780,763,790, and the highest BRKR revenue forecast at $526,068,691,814. On average, 5 Wall Street analysts forecast BRKR's revenue for 2026 to be $538,872,895,904, with the lowest BRKR revenue forecast at $524,141,855,878, and the highest BRKR revenue forecast at $567,991,786,751.

In 2027, BRKR is forecast to generate $564,879,415,697 in revenue, with the lowest revenue forecast at $559,616,877,803 and the highest revenue forecast at $575,122,596,906.

What is BRKR's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: BRKR) forecast ROA is 6.33%, which is lower than the forecast US Medical Devices industry average of 11.89%.

What is BRKR's Price Target?

According to 7 Wall Street analysts that have issued a 1 year BRKR price target, the average BRKR price target is $44.43, with the highest BRKR stock price forecast at $50.00 and the lowest BRKR stock price forecast at $38.00.

On average, Wall Street analysts predict that Bruker's share price could reach $44.43 by Aug 5, 2026. The average Bruker stock price prediction forecasts a potential upside of 38.36% from the current BRKR share price of $32.11.

What is BRKR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BRKR) Bruker's current Earnings Per Share (EPS) is $0.52. On average, analysts forecast that BRKR's EPS will be $2.00 for 2025, with the lowest EPS forecast at $1.95, and the highest EPS forecast at $2.05. On average, analysts forecast that BRKR's EPS will be $2.32 for 2026, with the lowest EPS forecast at $2.13, and the highest EPS forecast at $2.58. In 2027, BRKR's EPS is forecast to hit $2.64 (min: $2.50, max: $2.91).

What is BRKR's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: BRKR) forecast ROE is 22.04%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.